Sharpepoint LLC
- SEC CIK
- 0002046822
- Latest filing
- Jul 29, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by Sharpepoint LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,000
- Value
- $470.4K
- % of portfolio
- 0.2%
- Quarters held
- 6
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,000 | $470.4K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 10,000 | $189.0K | 0.1% | −135−1.3% | Reduced | Holders |
| Q4 2025 | 10,135 | $135.7K | 0.1% | +10,135 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −10,165−100.0% | Sold out | Holders |
| Q2 2025 | 10,165 | $66.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,165 | $64.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,165 | $70.7K | 0.1% | – | No prior filing | Holders |